A novel EndMT inhibitor, xanthotoxin, attenuates non-alcoholic fatty liver disease by acting as TGFβR2 antagonist

Xiaona Zhao, Fangjie Xia, Zixu Dong, Wenyang Huang, Xinxin Kong, Zhoujun Cui, Maocai Yan, Honggang Gao, Ruixue Rong, Minghui Wang, Guoqing Liu, Zejin Zhang, Jing Zhang, Tao Yuan, Huiying Cai, Zhenzhen Yan, Lin Zhu, Wei Qin

Open source

DOI
10.1016/j.phymed.2025.156823
Published
2025-07
Container
Phytomedicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.phymed.2025.156823,
  title = {A novel EndMT inhibitor, xanthotoxin, attenuates non-alcoholic fatty liver disease by acting as TGFβR2 antagonist},
  author = {Xiaona Zhao and Fangjie Xia and Zixu Dong and Wenyang Huang and Xinxin Kong and Zhoujun Cui and Maocai Yan and Honggang Gao and Ruixue Rong and Minghui Wang and Guoqing Liu and Zejin Zhang and Jing Zhang and Tao Yuan and Huiying Cai and Zhenzhen Yan and Lin Zhu and Wei Qin},
  year = {2025},
  journal = {Phytomedicine},
  doi = {10.1016/j.phymed.2025.156823},
  url = {https://doi.org/10.1016/j.phymed.2025.156823}
}

RIS

TY  - JOUR
TI  - A novel EndMT inhibitor, xanthotoxin, attenuates non-alcoholic fatty liver disease by acting as TGFβR2 antagonist
AU  - Xiaona Zhao
AU  - Fangjie Xia
AU  - Zixu Dong
AU  - Wenyang Huang
AU  - Xinxin Kong
AU  - Zhoujun Cui
AU  - Maocai Yan
AU  - Honggang Gao
AU  - Ruixue Rong
AU  - Minghui Wang
AU  - Guoqing Liu
AU  - Zejin Zhang
AU  - Jing Zhang
AU  - Tao Yuan
AU  - Huiying Cai
AU  - Zhenzhen Yan
AU  - Lin Zhu
AU  - Wei Qin
PY  - 2025
JO  - Phytomedicine
DO  - 10.1016/j.phymed.2025.156823
UR  - https://doi.org/10.1016/j.phymed.2025.156823
ER  - 

APA

Zhao, X., Xia, F., Dong, Z., Huang, W., Kong, X., Cui, Z., Yan, M., Gao, H., Rong, R., Wang, M., Liu, G., Zhang, Z., Zhang, J., Yuan, T., Cai, H., Yan, Z., Zhu, L., & Qin, W. (2025). A novel EndMT inhibitor, xanthotoxin, attenuates non-alcoholic fatty liver disease by acting as TGFβR2 antagonist. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.156823

Source records